Crossbow Laser Sales Lift IPG Photonics Profit
Shipments to Lockheed Martin drove a 15 percent sales rise, a sign that fiber laser weapons are moving into production.
Updated on Nov. 4, 2026 in Quantum Computing

IPG Photonics reported $288 million in sales for the September 2026 quarter, up 15 percent year-on-year, with pre-tax income of $28.4 million. The results are reported financials, not a new product or research milestone.
Why it matters
The quarter's gains were driven in part by shipments of Crossbow laser weapons to lead customer Lockheed Martin, a sign that high-power fiber laser systems are moving from development into defense procurement. Its stock, however, has lost more than half its value since a February high above $150, leaving it near $74.
The company reported $288 million in quarterly sales and $28.4 million in pre-tax income for the September 2026 quarter, against prior-year figures that roughly halved on profit. Crossbow laser shipments to Lockheed Martin contributed to the period, but the filing does not separate their revenue from the rest of the business.
The players
IPG Photonics
A fiber laser manufacturer whose products span industrial cutting, additive manufacturing and defense systems, including the Crossbow laser weapon.
Lockheed Martin
A major U.S. defense prime contractor and the lead customer for IPG Photonics' Crossbow laser weapons.
Lumibird Medical
A French medical laser company, whose acquisition by IPG Photonics is expected to close shortly and targets a roughly $2 billion addressable medical market.
The details
IPG Photonics makes high-power fiber lasers, which generate light in optical fibers doped with rare-earth elements and amplify it to industrial or weapons power levels. The Crossbow weapon is one such laser system, and the company shipped a significant number of units to Lockheed Martin during the quarter. IPG also secured new additive manufacturing business in Europe, where lasers fuse metal powder layer by layer into finished parts.
Timeline
February 2026: IPG Photonics stock reached a short-term high above $150.
September 2026 quarter: the company reported $288 million in sales and $28.4 million in pre-tax income.
End of 2026: remaining Crossbow shipments to Lockheed Martin are due to be completed.
Fourth quarter 2026: the company expects sales between $265 million and $295 million.
Shortly: the Lumibird Medical acquisition is expected to close.
The Tech Race
IPG Photonics' fiber laser business sits within a competitive field of high-power laser developers pursuing defense and industrial applications. The company's diversification into medical lasers through the Lumibird Medical deal extends that competitive footprint beyond its core industrial and defense customers.
The Lumibird Medical acquisition, if it closes as expected, would add medical laser products to IPG Photonics' portfolio. Crossbow shipments are a defense program, so their effect on civilian users is limited to the broader spread of fiber laser technology.
The takeaway
Watch whether IPG Photonics meets its fourth-quarter guidance of $265 million to $295 million in sales. Also watch whether the Lumibird Medical acquisition closes as expected, since that will show whether the company's medical push takes hold.
What happens next
IPG Photonics expects its Lumibird Medical acquisition to close shortly, and it guides to fourth-quarter 2026 sales of $265 million to $295 million.
Further reading
For broader context on the high-power laser technology behind this quarter's results, see Quantum Computing coverage in the United States.
Source note: This article includes information reported by Optics.





